Thursday, March 23, 2023
  • Login
Euro Times
No Result
View All Result
  • Home
  • Finance
  • Business
  • World
  • Politics
  • Markets
  • Stock Market
  • Cryptocurrency
  • Investing
  • Health
  • Technology
  • Home
  • Finance
  • Business
  • World
  • Politics
  • Markets
  • Stock Market
  • Cryptocurrency
  • Investing
  • Health
  • Technology
Euro Times
No Result
View All Result

Everest Kanto Cylinder Q2 Results Review

by IDBI Capital
November 17, 2022
in Business
Reading Time: 2 mins read
A A
0
Home Business
Share on FacebookShare on Twitter


BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy. 

Everest Kanto Cylinder Ltd.’s Q2 FY23 result was lower than our expectations. Its sales fell by 11% QoQ to Rs 3,397 million mainly led by weak demand and rising competition.

Nevertheless, Industrial segment reported stable performance which supported the topline from further downfall.

Ebitda stood at Rs 359 million (down 41% QoQ, down 68% YoY) and Ebitda margin contracted 1,590 bps YoY to 11% on account of lower topline growth and negative operating leverage.

Everest Kanto Cylinder’ net profit fell by 74% YoY at Rs 185 million. Sharp rise in prices of compressed natural gas across India has led to lower demand for CNG vehicles.

Hence, we lower our FY23/24 sales forecasts by 12%/9%. Our FY23/24 Ebitda forecast stand lower by 29%/26%.

Click on the attachment to read the full report:

DISCLAIMER

This report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.





Source link

Tags: cylinderEverestKantoResultsReview
Previous Post

Only a revived economy can save China’s property industry

Next Post

Schwazze Stock: Executing Well In Difficult Economic Conditions (OTCMKTS:SHWZ)

Related Posts

Craftsman Automation – DR Axion Good Asset At Reasonable Price: Motilal Oswal

by Motilal Oswal Financial Services
March 23, 2023
0

BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset...

Clalit teams with Harvard on ‘imitating’ clinical trials

by Gali Weinreb
March 23, 2023
0

Gali Weinreb Big data technologies are changing the way clinical trials are conducted and transforming the way data about...

US Federal Reserve raises policy rate by 25 bps; 9th straight hike

by Euro Times
March 22, 2023
0

US Federal Reserve raised the policy rate by 25 basis points. The Federal Open...

India, the largest arms importer

by Euro Times
March 23, 2023
0

India’s arms imports continue to be the highest globally with 45 per cent of its shipments coming from Russia. The...

SoFi to boost FDIC insurance coverage to $2M for checking, savings members (NASDAQ:SOFI)

by Euro Times
March 22, 2023
0

Justin Sullivan/Getty Images News SoFi Technologies (NASDAQ:SOFI) will offer members with checking or savings accounts access up to $2M of...

Stellantis to invest €130M in German assembly plant By Investing.com

by Investing.com
March 22, 2023
0

© Reuters. Stellantis (STLA) to invest €130M in German assembly plant By Michael Elkins Stellantis (NYSE:) announced Wednesday that the American...

Next Post

Schwazze Stock: Executing Well In Difficult Economic Conditions (OTCMKTS:SHWZ)

Big emerging-market companies worry investors

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Arcus Biosciences: Anti-TIGIT Therapy On Track With ARC-7 Results (NYSE:RCUS)

March 23, 2023

Craftsman Automation – DR Axion Good Asset At Reasonable Price: Motilal Oswal

March 23, 2023

Increasing Supply At Key Resistance Puts Avalanche Coin On 15% Downside Risk

March 23, 2023

Top 40 High-Yield Blue-Chip U.K. Stocks: Spring 2023

March 23, 2023

Big jump in migrants crossing Panama’s dangerous Darien Gap

March 23, 2023

The Banking Crisis for Dummies And why it means more inflation ahead. – Investment Watch

March 23, 2023
Euro Times

Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.

CATEGORIES

  • Business
  • Cryptocurrency
  • Finance
  • Health
  • Investing
  • Markets
  • Politics
  • Stock Market
  • Technology
  • Uncategorized
  • World

LATEST UPDATES

Arcus Biosciences: Anti-TIGIT Therapy On Track With ARC-7 Results (NYSE:RCUS)

Craftsman Automation – DR Axion Good Asset At Reasonable Price: Motilal Oswal

  • Disclaimer
  • Privacy Policy
  • DMCA
  • Cookie Privacy Policy
  • Terms and Conditions
  • Contact us

Copyright © 2022 - Euro Times.
Euro Times is not responsible for the content of external sites.

No Result
View All Result
  • Home
  • Finance
  • Business
  • World
  • Politics
  • Markets
  • Stock Market
  • Cryptocurrency
  • Investing
  • Health
  • Technology

Copyright © 2022 - Euro Times.
Euro Times is not responsible for the content of external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In